Druss B.Evidence based medicine: does it make a difference? Use wisely. BMJ. 2005;330:92.
2.
Hallenback J.Evidence-based medicine and palliative care . J Palliat Med. 2008;11:2-4.
3.
Rogers WAEvidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groups. J Med Ethics . 2004;30:141-145.
4.
Taylor ALSERMs, ethnicity, and clinical trials: opportunities and challenges . Ann N Y Acad Sci. 2001;949: 292-294.
5.
Moye LA, Powell JHEvaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered. J Natl Med Assoc. 2001 ;93(suppl): 29S-34S.
6.
Swanson GM, Bailar JCSelection and description of cancer clinical trials: Opportunities lost and rediscovered. J Natl Med Assoc. 2001 ;93(Suppl):29S-34S.
7.
Heiat A., Gross C., Krumholz H.Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162:1682-1688.
8.
Sateren W., Trimble E., Brawley O., et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
9.
Turner EH, Matthews AM, Linardatos E., Tell RA, Rosenthal R.Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
10.
Friedman LS , Richter EDRelationship between conflicts of interest and research results. J Gen Intern Med. 2004 ;19:51-56.
11.
Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richrdson WSEvidence based medicine: what it is and what it isn't. BMJ . 1996;312:71-72.
12.
Tonelli MRThe limits of evidence-based medicine. Respir Care . 2001;46:1435-1440.
